Repligen | RGEN - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.13B 23.36M 2026-03
Bio Techne USD 214.56M 29.95M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Bruker USD 542.7M 2.2M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
General Electric Aerospace USD 22.18B 6.89B 2026-03
Henry Schein USD 1.72B 68M 2026-03
Illumina USD 738M 116M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Mettler Toledo International USD 708.21M 70.04M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pfizer USD 16.17B 332M 2026-03
Repligen USD 151.55M 7.03M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Standard Biotools USD 41.64M 28.21M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Waters USD 1.76B 930.16M 2026-03
West Pharmaceutical Services USD 685.6M 111.2M 2026-03